FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016289886> ?p ?o ?g. }

• W2016289886 endingPage "2235" @default.
• W2016289886 startingPage "2229" @default.
• W2016289886 abstract "Thirty-six patients previously treated with surgery, radiation therapy and chemotherapy with a nitrosourea for malignant supratentorial gliomas received a combination of ifosfamide, carboplatin and etoposide (ICE) at tumour progression. Carboplatin and etoposide were both given at a dose of 75-100 mg/m2/day for 3 days, whereas ifosfamide doses ranged from 750 mg/m2/day to 1500 mg/m2/ day for 3 days, according to haematological tolerance. Treatment was repeated every 4 weeks. A minimum of three courses was required to evaluate the response unless the patient had rapid tumour progression. Grade III and IV haematological toxicity occurred in 15 patients (42%) and was lethal in one patient. Grade II hepatic toxicity was observed in one patient. Five complete (CR) and five partial responses (PR) were noted. 9 patients had stable disease (SD) after a minimum of three courses. CR + PR + SD was 53% (19/36). The median time to tumour progression (MTTP) was 13 weeks. Median survival (MST) was 29 weeks (44 weeks for R + S patients and 17 weeks for patients with progressing disease). This study suggests that the ICE combination is active in recurrent supratentorial malignant gliomas after failure of surgery, radiation therapy and chemotherapy, but at the cost of substantial haematological toxicity." @default.
• W2016289886 created "2016-06-24" @default.
• W2016289886 creator A5002021280 @default.
• W2016289886 creator A5008158125 @default.
• W2016289886 creator A5027944082 @default.
• W2016289886 creator A5039803490 @default.
• W2016289886 creator A5073592389 @default.
• W2016289886 creator A5073703583 @default.
• W2016289886 creator A5089019258 @default.
• W2016289886 date "1996-12-01" @default.
• W2016289886 modified "2023-09-27" @default.
• W2016289886 title "Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study" @default.
• W2016289886 cites W1847381023 @default.
• W2016289886 cites W1868719232 @default.
• W2016289886 cites W1881843864 @default.
• W2016289886 cites W1944104521 @default.
• W2016289886 cites W1959628099 @default.
• W2016289886 cites W1964562817 @default.
• W2016289886 cites W1966978209 @default.
• W2016289886 cites W1967964100 @default.
• W2016289886 cites W1971320685 @default.
• W2016289886 cites W1977703854 @default.
• W2016289886 cites W1979876194 @default.
• W2016289886 cites W2015131798 @default.
• W2016289886 cites W2016103375 @default.
• W2016289886 cites W2020896073 @default.
• W2016289886 cites W2022216238 @default.
• W2016289886 cites W2029409133 @default.
• W2016289886 cites W2034481315 @default.
• W2016289886 cites W2035713326 @default.
• W2016289886 cites W2038835567 @default.
• W2016289886 cites W2040785900 @default.
• W2016289886 cites W2043005631 @default.
• W2016289886 cites W2050887070 @default.
• W2016289886 cites W2064542358 @default.
• W2016289886 cites W2065634769 @default.
• W2016289886 cites W2071434086 @default.
• W2016289886 cites W2082425186 @default.
• W2016289886 cites W2149745369 @default.
• W2016289886 cites W2170949017 @default.
• W2016289886 cites W2227545313 @default.
• W2016289886 cites W2242428650 @default.
• W2016289886 cites W2288042566 @default.
• W2016289886 cites W2326557437 @default.
• W2016289886 cites W4232461964 @default.
• W2016289886 cites W4293241248 @default.
• W2016289886 doi "https://doi.org/10.1016/s0959-8049(96)00299-7" @default.
• W2016289886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9038603" @default.
• W2016289886 hasPublicationYear "1996" @default.
• W2016289886 type Work @default.
• W2016289886 sameAs 2016289886 @default.
• W2016289886 citedByCount "44" @default.
• W2016289886 countsByYear W20162898862012 @default.
• W2016289886 countsByYear W20162898862013 @default.
• W2016289886 countsByYear W20162898862014 @default.
• W2016289886 countsByYear W20162898862017 @default.
• W2016289886 countsByYear W20162898862023 @default.
• W2016289886 crossrefType "journal-article" @default.
• W2016289886 hasAuthorship W2016289886A5002021280 @default.
• W2016289886 hasAuthorship W2016289886A5008158125 @default.
• W2016289886 hasAuthorship W2016289886A5027944082 @default.
• W2016289886 hasAuthorship W2016289886A5039803490 @default.
• W2016289886 hasAuthorship W2016289886A5073592389 @default.
• W2016289886 hasAuthorship W2016289886A5073703583 @default.
• W2016289886 hasAuthorship W2016289886A5089019258 @default.
• W2016289886 hasConcept C126322002 @default.
• W2016289886 hasConcept C126894567 @default.
• W2016289886 hasConcept C141071460 @default.
• W2016289886 hasConcept C2776694085 @default.
• W2016289886 hasConcept C2777506904 @default.
• W2016289886 hasConcept C2778119113 @default.
• W2016289886 hasConcept C2778239845 @default.
• W2016289886 hasConcept C2778822529 @default.
• W2016289886 hasConcept C2781451048 @default.
• W2016289886 hasConcept C29730261 @default.
• W2016289886 hasConcept C31760486 @default.
• W2016289886 hasConcept C509974204 @default.
• W2016289886 hasConcept C71924100 @default.
• W2016289886 hasConcept C90924648 @default.
• W2016289886 hasConceptScore W2016289886C126322002 @default.
• W2016289886 hasConceptScore W2016289886C126894567 @default.
• W2016289886 hasConceptScore W2016289886C141071460 @default.
• W2016289886 hasConceptScore W2016289886C2776694085 @default.
• W2016289886 hasConceptScore W2016289886C2777506904 @default.
• W2016289886 hasConceptScore W2016289886C2778119113 @default.
• W2016289886 hasConceptScore W2016289886C2778239845 @default.
• W2016289886 hasConceptScore W2016289886C2778822529 @default.
• W2016289886 hasConceptScore W2016289886C2781451048 @default.
• W2016289886 hasConceptScore W2016289886C29730261 @default.
• W2016289886 hasConceptScore W2016289886C31760486 @default.
• W2016289886 hasConceptScore W2016289886C509974204 @default.
• W2016289886 hasConceptScore W2016289886C71924100 @default.
• W2016289886 hasConceptScore W2016289886C90924648 @default.
• W2016289886 hasIssue "13" @default.
• W2016289886 hasLocation W20162898861 @default.
• W2016289886 hasLocation W20162898862 @default.
• W2016289886 hasOpenAccess W2016289886 @default.
• W2016289886 hasPrimaryLocation W20162898861 @default.

• next